FDA Wants Promotional “Targets” From Sponsors Throughout Drug Development
Executive Summary
Sponsors should provide FDA with proposed promotional claims at the beginning of the drug development process, the agency said in a draft guidance
You may also be interested in...
Complete Submissions Are Key To Good Review Management Principles – FDA
As FDA rolls out its Good Review Management Principles - its attempt to improve FDA's timely review of drug applications through professional best practices - the agency is stressing the importance of sponsors submitting complete applications to facilitate this process
Complete Submissions Are Key To Good Review Management Principles – FDA
As FDA rolls out its Good Review Management Principles - its attempt to improve FDA's timely review of drug applications through professional best practices - the agency is stressing the importance of sponsors submitting complete applications to facilitate this process
Complete Submissions Are Key To Good Review Management Principles – FDA
As FDA rolls out its Good Review Management Principles – its attempt to improve FDA’s timely review of drug applications through professional best practices – the agency is stressing the importance of sponsors submitting complete applications to facilitate this process.